Objective The purpose of this paper is to determine whether sites of distant recurrence are associated with specific locations of primary disease in colon cancer. Methods A cohort including all patients (n=947) undergoing a segmental colonic resection for colon cancer at our center (2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011) comparing site-specific metastatic presentation and recurrence rates, as well as their respective multivariable American Joint Committee on Cancer (AJCC) stage-adjusted hazard ratios (mHR). Results Right-sided colectomies (n=557) had a lower overall metastasis rate (24.8 % vs. 31.8 %; P=0.017; mHR=1.24 [95% CI: 0.96-1.60]; P=0.011) due to significantly lower pulmonary metastasis in follow-up (2.7 % vs. 9 %; P<0.001; mHR=0.32 [95% CI: 0.17-0.58]; P=0.001) and lower overall liver metastasis rate (15.6 vs. 22.1 %; P=0.012; mHR=0.74 [95% CI: 0.55-0.99];P=0.050). Left colectomies (n=127) had higher rates of liver metastasis during follow-up (9.4 % vs. 4.8 %; P=0.029; mHR=1.64 [95% CI: 0.86-3.15]; P=0.134). Sigmoid resections (n=238) had higher baseline rates of liver metastasis (17.1 % vs. 11.3 %; P=0.015) and higher cumulative rates of lung (12.2 % vs. 5.4 %; P<0.001; mHR=2.26 [95 % CI: 1.41-3.63]; P=0.001) and brain metastases (2.3 % vs. 0.6 %; P=0.033; mHR=4.03 [95% CI: 1.14-14.3]; P=0.031). Other sites of metastasis, including the (retro) peritoneum, omentum, ovary, and bone, did not yield significant differences. Conclusions Important variations in site-specific rates of metastatic disease exist within major resection regions of colon cancer. These variations may be important to consider when evaluating options for adjuvant treatment and surveillance after resection of the primary disease.
Introduction
In primary tumors of the colon, the presence of locoregional and distant metastasis has important consequences for the prognosis and the preferred treatment approach for the individual patient. 1 In the absence of clinical and radiological suspicion of distant metastasis, treatment will be surgical with curative intent in virtually all cases. If lymphatic disease is also absent in the surgical resection specimen, adjuvant therapy is rarely required, and most patients will only need regular follow-up to monitor recurrence.
Colonic malignancies have a tendency to spread to the pericolic lymphatics, followed by more distant lymph node stations, with distant hematologic spread usually seen as a last stage of dissemination. These steps are however not obligatorily sequential, nor is lymphatic spread a prerequisite of distant metastasis, as hematologic spread can occur in the absence of involved lymph nodes, even in necropsies. 2 Distant metastatic spread is present in about one in five patients at baseline, 3 most often to the liver, followed by the lungs, and the peritoneum. Less typical sites of metastasis once colonic tumor cells reach the systemic arterial circulation are numerous and include the bones and bone marrow, the brain, and more rarely other parts of the gastrointestinal tract, as well as other solid organs including the kidney, spleen, and adrenal glands.
Despite being studied in detail, most of the research aimed at identifying patterns of metastasis combine patients affected by cancers of the colon and rectum. 4 If colonic malignancies are studied separately, it will commonly be done by clustering all regions of the colon together. Considering that lymphovascular drainage passes through distinct and anatomically discrete vessels for right-sided, left-sided, and sigmoid tumors, it could potentially have a significant impact on the specific rates and patterns of metastatic spread. Our aim in this study is to verify whether metastasis patterns differ for each of the major resection regions in malignancies of the colon.
Patients and Methods
Data for this research was extracted from a prospectively maintained database that included all colon cancer patients treated surgically for colon cancer at the Massachusetts General Hospital in the 2004 through 2011 timeframe. From this dataset, all patients undergoing a primary, single-segment resection (i.e., right colectomy, left colectomy, or sigmoid resection, excluding total and transverse colectomies) were included for further analysis. Records were reviewed for presentation and admission characteristics. Baseline metastasis considered any metastatic disease that was suspected and confirmed within 30 days of the index procedure. Any metastasis identified past this limit will be considered metastasis during follow up.
Statistical Analysis
Statistical analysis was performed using SPSS statistical software (IBM Corp. Released 2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.). Statistical significance was defined as a two-sided P value of 0.05. Differences in dichotomous outcomes were assessed using a chi-square (χ 2 ) test. Significance of the differences in continuous outcomes over all three resection groups was performed using a Kruskal-Wallis H test, while any comparison between a single subgroup and the remainder of the population was performed through one-way analysis of variance (ANOVA) analysis. Lastly, differences in metastatic rates were assessed in multivariable analysis adjusted for baseline AJCC staging and accounting for any time-related biases using Cox proportional hazards models, which will compare univariate hazard ratio (HR) and 95 % confidence interval (95% CI) of the events occurring with the multivariate HR.
Results

Baseline Characteristics
Baseline characteristics are shown in Table 1 . Baseline characteristics were not significantly different between the three major resection groups, except for age and the rate of preexisting polyposis, which did differ significantly between groups (both P<0.001). In terms of group-specific differences compared with the remainder of the population, right-sided resections were shown to have significantly fewer male patients (46.9 vs. 54.4 %; P = 0.022) and higher rates of preexisting polyposis (15.1 vs. 6.9 %; P=0.0002). Sigmoid resections had a significantly higher proportion of male patients (55.1 vs. 47.9 %; P= 0.04), obese patients (34 vs. 26.6 %; P=0.024), and current smokers (14.4 vs. 9.8 %; P= 0.04), while having significantly lower rates of preexisting polyposis (6.1 vs. 13.9 %; P=0.0015).
Perioperative Outcomes
All perioperative outcomes are shown in Table 2 . Right-sided procedures had a significantly shorter median procedure time (108 vs. 139 min; P<0.001), while sigmoid resections had a median admission that was 1 day shorter (4 vs. 5 days; P= 0.022). In terms of postoperative pathology, statistically significant variations existed between groups in rates of high- 
Follow-up and Recurrence
When outcomes were compared among all three major resection regions, statistically significant differences were found in rates of lung metastasis during follow-up (P<0.001), and significant differences in cumulative rates of liver (P=0.04) and lung (P<0.001) metastases. Median follow-up duration was similar in right, left, and sigmoid tumors at 42, 41, and 45 months, respectively, (P=0.33), and loss to follow-up rates of 4 %, 6.1 %, and 6.1 % (P=0.40). Mortality rates (P=0.36), duration of survival (P=0.35), and disease-free survival (P= 0.82) were not substantially different between major resection groups. With respect to specific regions, right-sided tumors had significantly lower rates of local recurrence (0.7 vs. 2.3 %; P=0.039) and lung metastasis (2.7 vs. 9.0 %; P<0.001) in follow-up, as well as lower cumulative rates of overall metastasis (24.8 vs. 31.8 %; P=0.017), mostly owing to the significantly higher cumulative rates of liver (15.6 vs. 22.1 %; P= 0.012) and lung metastasis (4.7 vs. 11 %; P<0.001). For leftsided resections, the overall percentage of metastatic recurrence was highest at 15 % (vs. 9.9 % in other resections; P= 0.083) likely related to the significantly higher rate of liver metastases during follow-up (9.4 vs. 4.8 % P = 0.029). Sigmoid resections had the highest rates of lung metastasis during follow-up (9.9 vs. 3.5 %; P<0.001), along with considerably higher overall rates of liver (22.4 vs. 16.7 %; P= 0.04) and lung metastases (12.2 vs. 5.4 %; P < 0.001). Incidentally, in stage II tumors, sigmoid resections were shown to have a longer disease-free survival duration (51 vs. 41 weeks; P=0.048) and survival duration (61 vs. 49 weeks; P=0.021). All long-term outcomes are shown in detail in Table 3 .
Multivariate Cox regression, as shown in Table 4 , demonstrates that differences in metastatic outcomes between 
Discussion
Malignancies of the colon are usually clustered as a single entity when patterns and incidence rates of metastasis are discussed. We hypothesized that the clinical reality is different, and that significant differences exist in metastatic patterns depending on the location of the primary tumor. We found that significant differences exist within the three primary resection regions in hematologic metastasis and with a smaller and nonsignificant trend in lymph node metastasis. Specifically, right-sided tumors had more clement metastatic outcomes, including lower rates of lymph node, overall distant metastasis, and lung metastasis. Left-sided tumors had significantly higher liver metastasis rates during follow up. Sigmoid tumors had considerably worse characteristics, including higher total rates of lung and brain metastasis and higher liver metastasis rates at baseline. These differences were found to be independent of baseline AJCC staging.
Earlier evidence confirms some of our findings: a 1980s long-term follow-up study at the Peter Bent Brigham Hospital of 281 curative resections gave indications that sigmoid resections were at the highest odds of recurrence 5 . The vast majority of the body of evidence is based on the left-right dichotomy in outcomes that was proposed over two decades ago. 6 Most of this research was aimed at site-specific (disease-free) survival, baseline characteristics, and staging, and only rarely focusing specifically on patterns of metastasis: 7 Using this left-right dichotomy, a German multicenter study demonstrated higher rates of pulmonary and liver metastasis in left-sided tumors;
8 on the other hand, however, a Japanese study covering a single-center cohort of 820 patients could not identify significant differences in sites of metastasis. 9 There are several possible explanations for the differences in metastatic patterns identified here. A first candidate is the sessile serrated pathway, which in the colon is mostly prominent in right-sided tumors and may be responsible for up to 16 % of all proximal colonic tumors. 10 Right-sided tumors have a clearly lower rate of metastasis, and with about 15 % of these tumors occurring through the sessile serrated pathway, this could explain the more indolent course of right-sided tumors in general, although evidence proving this effect is still too sparse to allow the assumption of a causal relationship. However, although we do not have specific pathologic data on previous polyps resected from patients in our cohort, we did note a markedly higher rate of preexisting polyposis in those patients with right-sided tumors, which supports this hypothesis. Secondly, other inherent differences in tumor genetics, mutation profiles and subsequent biology, and histologic subtype 11 may cause differences both in local behavior and later seed-and-soil characteristics. 12 Lastly and most intuitively, the analyzed colonic segments have anatomically distinct and discrete lymphatic and vascular drainage areas, which may well lead to different seeding patterns, as parts of the colonic drainage maybe more or less likely to reach the hepatic circulation.
This research clearly has its limitations: although the overall population size was large enough to identify overall population-level patterns in metastatic disease. It was too small to identify stage-specific differences between resection regions. Similarly, due to the limited number of patients tested for microsatellite instability or mutations (BRAF, KRAS, etc.), these investigations into genetic variation did not yield any meaningful findings in preliminary data exploration and were therefore not a significant contribution to the data described in this paper. Further research on the topic may well deliver important insights on the underlying effects of these mutations on the described differences in metastasis patterns. In conclusion, the applicability of the metastatic differences demonstrated here lies in the difference in the odds of having specific metastasis or pathological characteristics. These differ considerably depending on the region of the primary resection, and ideally, if these findings are confirmed in larger population studies, these differences have implications on the surveillance and adjuvant treatment of colonic malignancies, which could include a lower threshold for adjuvant therapy in left-sided disease and varied rates of surveillance computed tomography frequencies.
